Alychlo

Alychlo NV is a venture capital and private equity firm based in Merelbeke, Belgium, established in 2008. The firm focuses on both direct and indirect investments, with direct investments targeting sectors such as healthcare, particularly life sciences and biotechnology, as well as hospitality and leisure. Alychlo specializes in various investment strategies including middle market, later stage, turnaround, and growth capital investments, often preferring minority stakes. The firm's indirect investments encompass private equity and venture capital funds, in addition to real estate funds. Alychlo typically invests between 10 million and 50 million euros and is particularly active in the European market, with a strong emphasis on Belgium. The firm also engages in secondary investing, allowing for portfolio company interests.